tirzepatide for inflammation Joint Pain & GLP-1 drugs calm inflammation beyond

This study adds to the body of literature supporting the beneficial effects of semaglutide in people with overweight and obesity without diabetes, which is so necessary as we continue to navigate the complex landscape of insurance coverage of these medications in people who do not have diabetes, Shiara Ortiz-Pujols, MD, MPH, an obesity medicine physician at Staten Island University Hospital, told Healthline

Patients who do best are usually the ones who are willing to stay engaged, report what they are feeling, and make practical changes alongside treatment instead of waiting for the medication to carry the whole process by itself

Scenario 2: Cardiovascular Disease or High Risk Consider a 60-year-old patient with established coronary artery disease

Mixes and tastes great, and definitely shows results.* Was this helpful